141 related articles for article (PubMed ID: 2564000)
1. H2-antagonists and carmustine.
Dorr RT; Soble MJ
J Cancer Res Clin Oncol; 1989; 115(1):41-6. PubMed ID: 2564000
[TBL] [Abstract][Full Text] [Related]
2. Interaction of cimetidine but not ranitidine with cyclophosphamide in mice.
Dorr RT; Soble MJ; Alberts DS
Cancer Res; 1986 Apr; 46(4 Pt 1):1795-9. PubMed ID: 3948164
[TBL] [Abstract][Full Text] [Related]
3. Cimetidine enhances cisplatin toxicity in mice.
Dorr RT; Soble MJ
J Cancer Res Clin Oncol; 1988; 114(1):1-2. PubMed ID: 3350834
[TBL] [Abstract][Full Text] [Related]
4. L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
Warrington RC; Fang WD
Br J Cancer; 1989 Nov; 60(5):652-6. PubMed ID: 2803940
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice.
Takenaga M; Igarashi R; Tsuji H; Mizushima Y
Jpn J Cancer Res; 1993 Oct; 84(10):1078-85. PubMed ID: 8226282
[TBL] [Abstract][Full Text] [Related]
6. Cimetidine enhancement of cyclophosphamide antitumour activity.
Dorr RT; Alberts DS
Br J Cancer; 1982 Jan; 45(1):35-43. PubMed ID: 7059463
[TBL] [Abstract][Full Text] [Related]
7. Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.
Roosen N; Doz F; Yeomans KL; Dougherty DV; Rosenblum ML
Cancer Chemother Pharmacol; 1994; 34(5):385-92. PubMed ID: 7520843
[TBL] [Abstract][Full Text] [Related]
8. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
9. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
10. Elimination of EL-4 and L1210 murine tumors by 1,3-bis (2-chloroethyl)-1-nitrosourea requires an intact immune response.
Steele TA; Cox DC
Proc Soc Exp Biol Med; 1996 May; 212(1):63-8. PubMed ID: 8618953
[TBL] [Abstract][Full Text] [Related]
11. The chemopreventive effect of dimethylthiourea against carmustine-induced myelotoxicity in rats.
El-Sayed el-SM; Abdel-Aziz AA; Saleh S; Saad AS
Food Chem Toxicol; 2011 Sep; 49(9):1965-9. PubMed ID: 21620922
[TBL] [Abstract][Full Text] [Related]
12. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
14. Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity.
Sensi M; Bergomi M; Formelli F; Parmiani G
Int J Cancer; 1990 Dec; 46(6):1088-94. PubMed ID: 2249896
[TBL] [Abstract][Full Text] [Related]
15. Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kehrer JP; Klein-Szanto AJ
Cancer Res; 1985 Nov; 45(11 Pt 2):5707-13. PubMed ID: 4053044
[TBL] [Abstract][Full Text] [Related]
16. Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Valeriote F; Lynch R; Medoff G; Tolen S; Dieckman J
J Natl Cancer Inst; 1978 Aug; 61(2):399-402. PubMed ID: 277727
[TBL] [Abstract][Full Text] [Related]
17. Treatment of primary radiogenic C57BL mouse cell leukemia/lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy and adjuvant cellular therapy.
Maruyama Y; Feola JM; Kryscio R
Jpn J Cancer Res; 1985 Dec; 76(12):1236-43. PubMed ID: 3005211
[TBL] [Abstract][Full Text] [Related]
18. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
[TBL] [Abstract][Full Text] [Related]
19. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.
Aronin PA; Mahaley MS; Rudnick SA; Dudka L; Donohue JF; Selker RG; Moore P
N Engl J Med; 1980 Jul; 303(4):183-8. PubMed ID: 7383088
[TBL] [Abstract][Full Text] [Related]
20. Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.
Berger MR; Henne T; Bedford P
J Cancer Res Clin Oncol; 1985; 110(3):185-90. PubMed ID: 4077917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
